Hints and tips:
Related Special Reports
...initial list of 10 drugs to face price negotiations includes a diabetes pill called Jardiance sold by Boehringer Ingelheim and Eli Lilly; a medicine to prevent strokes called Eliquis made by Pfizer and Bristol...
...Vectura, which is run separately, has been investing in R&D, plans a new “inhalation centre of excellence” in Bristol, and hired a new boss from Novartis when its chief executive and finance director left...
...A version of this article was first published by Nikkei Asia on July 27, 2023. ©2023 Nikkei Inc. All rights reserved....
...Merck, Bristol Myers Squibb and Amgen have all used these aggressive tactics to protect blockbuster drugs from competition, said O’Reilly....
...But the plan was blasted as “completely unnecessary” by Peter Hargreaves, the co-founder and largest shareholder in the Bristol-based company....
...A coalition of ethical investors have asked Johnson & Johnson, Merck, Pfizer, Eli Lilly, Gilead, Amgen, Regeneron, Bristol Myers Squibb and AbbVie to publish a report on the process they follow when applying...
...Last year, US drugmaker Bristol Myers Squibb said it could divert investment away from the UK because of the increasing clawbacks....
...Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series of bolt-on acquisitions by pharmaceutical companies looking to bolster their drug pipelines....
...Talks with the UK government, which previously offered the company a site near Bristol, are continuing....
...SeaGen also recently signed a partnership with French drugmaker Sanofi and has agreements with Takeda and Bristol Myers Squibb among others. SeaGen declined to comment....
...Given its success in London, Stocked will travel to other cities in the UK, with a possible Christmas event in Manchester, and then Bristol in the new year....
...It exited its position in generic drugs maker Teva and sold more than 70 per cent of its remaining shares in AbbVie and Bristol-Myers Squibb....
...Even though its balance sheet is smaller than rivals such as JPMorgan and Bank of America, it has tapped its relationship with Japan’s Mitsubishi UFJ to finance huge loans before, including $33.5bn for Bristol-Myers...
...The company markets Reblozyl, a drug that treats anaemia in certain blood disorders, in the US, Europe and Canada in collaboration with Bristol-Myers Squibb, which owns an 11.5 per cent stake in Acceleron...
...J&J shares trade on a multiple of 18 times forward earnings, well above Pfizer’s 12 times and Bristol-Myers Squibb’s 9 times. Duato will have to deliver on the vaccine front to justify this premium....
...Pfizer, AbbVie and Bristol-Myers Squibb all have blockbuster drugs due to lose exclusivity soon and have recently sealed multibillion-dollar deals....
...Berkshire reduced its stakes in drugmakers including Merck, Bristol-Myers Squibb and AbbVie in the first quarter, cut more than half of its holding in oil major Chevron, and sold the entirety of its positions...
.../ From Gene Feder, Professor of Primary Health Care, Bristol Medical School, University of Bristol, Bristol, UK...
...It increased its stakes in AbbVie, Bristol-Myers Squibb and Merck, but sold out of Pfizer....
...Berkshire’s new stake accounted for 1.3 per cent of Bristol-Myers shares outstanding, 1.2 per cent of AbbVie, 0.9 per cent of Merck and less than 0.1 per cent of Pfizer....
...“We’re cutting down huge areas of rainforest which are not easy to rebuild,” said Daniela Schmidt, professor in palaeobiology at the University of Bristol....
...wind industry after record installations (FT) Tokyo Olympics ceremonies chief resigns over sexist ‘Olympig’ remark (Nikkei) Toshiba investors secure landmark win in clash with management (FT) Japan Inc...
...Finally, mass vaccination centres will be used to vaccinate the wider community at a range of venues including the London Excel centre, Epsom racecourse, Manchester tennis club, Ashton Gate stadium in Bristol...
...It is in the process of changing the entity’s name to 27Health Inc, subject to approval from US regulators....
...(Bloomberg) News round-up Bristol-Myers Squibb to buy heart treatment maker for $13.1bn (FT + Lex) France’s Engie sells €3.4bn stake in Suez (FT) HPS raises $9bn as investors race into direct lending...
International Edition